Palisade Bio (PALI) Assets (2010 - 2026)

Palisade Bio (PALI) has 17 years of Assets data on file, last reported at $133.3 million in Q1 2026.

• Assets for Q1 2026 came in at $133.3 million, up 1527.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $133.3 million (up 1527.78% YoY), and the FY2025 annual result was $134.3 million, up 1134.78% from the prior year.
• Assets fell to $133.3 million in Q1 2026 per PALI's latest filing, from $134.3 million in the prior quarter.
• Over five years, Assets peaked at $134.3 million in Q4 2025 and troughed at $6.7 million in Q2 2025.
• A 5-year average of $26.4 million and a median of $12.9 million in 2024 frame the typical range for Assets.
• The sharpest annual moves came in 2025 and 2026: Assets slumped 48.2% in 2025, then soared 1527.78% in 2026.
• A 5-year view of Assets shows it stood at $15.8 million in 2022, then decreased by 10.85% to $14.1 million in 2023, then retreated by 22.57% to $10.9 million in 2024, then soared by 1134.78% to $134.3 million in 2025, then decreased by 0.77% to $133.3 million in 2026.
• Business Quant data shows PALI's Assets at $133.3 million in Q1 2026, $134.3 million in Q4 2025, and $7.0 million in Q3 2025.